LLY vs MRK
Eli Lilly and Company · Merck & Company Inc
Relative return (rebased to 100)
Key stats
| Metric | LLY | MRK |
|---|---|---|
| Price | $1,115.68 | $128.00 |
| Market Cap | $1.05T | $316.14B |
| P/E | 50.91 | 17.32 |
| P/B | 33.68 | 6.89 |
| P/S | 16.12 | 4.86 |
| ROE | 66.2% | 39.8% |
| Net Margin | 31.7% | 28.1% |
| Gross Margin | — | — |
| Revenue Growth | 44.7% | 1.3% |
| Dividend Yield | 0.56% | 2.56% |
| EPS | $21.92 | $7.39 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.